Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 5 TO THE FORM S-1 - Vyant Bio, Inc. | d254016ds1a.htm |
| EX-5.1 - OPINION OF LOWENSTEIN SANDLER PC - Vyant Bio, Inc. | d254016dex51.htm |
| EX-3.2 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Vyant Bio, Inc. | d254016dex32.htm |
| EX-3.4 - AMENDED AND RESTATED BYLAWS - Vyant Bio, Inc. | d254016dex34.htm |
| EX-10.46 - LETTER OF CREDIT FROM JP MORGAN CHASE BANK, N.A. DATED APRIL 19, 2012 - Vyant Bio, Inc. | d254016dex1046.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No. 5 to the Registration Statement (No. 333-178836) on Form S-1 of Cancer Genetics, Inc. and subsidiary of our report dated March 13, 2012, relating to our audits of the consolidated financial statements, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the caption “Experts” in such Prospectus.
| /s/ McGladrey & Pullen, LLP |
| Des Moines, Iowa |
| April 30, 2012 |